Serum sRAGE, sRANKL and osteoprotegerin in subgroups of rheumatoid arthritis patients: biomarkers associated with iron and disease status

References

• Tański W, Chabowski M, Jankowska-Polańska B, et al. Anaemia and iron deficiency in patients with rheumatoid arthritis and other chronic diseases. Postępy Hig Med Dośw. 2021;75(1):1–7. doi: 10.5604/01.3001.0014.7838.
   Google Scholar
• Jura-Półtorak A, Szeremeta A, Olczyk K, et al. Bone metabolism and RANKL/OPG ratio in rheumatoid arthritis women treated with TNF-α inhibitors. J Clin Med. 2021;10(13):2905. doi: 10.3390/jcm10132905.
   PubMed Web of Science ®Google Scholar
• Marinov L, Nikolova I, Mitov K, et al. Quality of life of patients with rheumatoid arthritis in Bulgaria. Pharmacia. 2016;63(2):22–29.
   Google Scholar
• Tofigh R, Hosseinpourfeizi M, Baradaran B, et al. Rheumatoid arthritis and non-coding RNAs; how to trigger inflammation. Life Sci. 2023;315:121367. doi: 10.1016/j.lfs.2023.121367.
   PubMed Web of Science ®Google Scholar
• Heaney ML, Golde DW. Soluble receptors in human disease. J Leukoc Biol. 1998;64(2):135–146. doi: 10.1002/jlb.64.2.135.
   PubMed Web of Science ®Google Scholar
• Jafari Nakhjavani MR, Jafarpour M, Ghorbanihaghjo A, et al. Relationship between serum-soluble receptor for advanced glycation end products (sRAGE) and disease activity in rheumatoid arthritis patients. Mod Rheumatol. 2019;29(6):943–948. doi: 10.1080/14397595.2018.1551107.
   PubMed Web of Science ®Google Scholar
• Wu SE, Chiu YL, Kao TW, et al. Elevated level of the soluble receptor for advanced glycation end-products involved in sarcopenia: an observational study. BMC Geriatr. 2021;21(1):531. doi: 10.1186/s12877-021-02487-1.
   PubMed Web of Science ®Google Scholar
• Nadali M, Lyngfelt L, Erlandsson MC, et al. Low soluble receptor for advanced glycation end products precedes and predicts cardiometabolic events in women With rheumatoid arthritis. Front Med (Lausanne). 2020;7:594622. doi: 10.3389/fmed.2020.594622.
   PubMed Web of Science ®Google Scholar
• Knani I, Bouzidi H, Zrour S, et al. Methylglyoxal: a relevant marker of disease activity in patients with rheumatoid arthritis. Dis Markers. 2018;2018:8735926–8735926. doi: 10.1155/2018/8735926.
   PubMed Web of Science ®Google Scholar
• Rzepka R, Dołęgowska B, Marczuk N, et al. Novel inflammatory markers of labor following premature preterm rupture of membranes. Clin Exp Obstet Gynecol. 2019;46(3):359–367. doi: 10.12891/ceog4607.2019.
   Web of Science ®Google Scholar
• Rzepka R, Dołęgowska B, Sałata D, et al. Soluble receptors for advanced glycation end products and receptor activator of NF-ΚB ligand serum levels as markers of premature labor. BMC Pregnancy Childbirth. 2015;15(1):134. doi: 10.1186/s12884-015-0559-3.
   PubMedGoogle Scholar
• Chen YS, Yan W, Geczy CL, et al. Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis. Arthritis Res Ther. 2009;11(2):R39. doi: 10.1186/ar2645.
   PubMed Web of Science ®Google Scholar
• Park MJ, Lee SH, Moon SJ, et al. Overexpression of soluble RAGE in mesenchymal stem cells enhances their immunoregulatory potential for cellular therapy in autoimmune arthritis. Sci Rep. 2016;6(1):35933. doi: 10.1038/srep35933.
   PubMedGoogle Scholar
• Yao Z, Getting SJ, Locke IC. Regulation of TNF-Induced osteoclast differentiation. Cells. 2021;11(1):132. doi: 10.3390/cells11010132.
   PubMed Web of Science ®Google Scholar
• Remuzgo-Martínez S, Genre F, López-Mejiás R, et al. Expression of osteoprotegerin and its ligands, RANKL and TRAIL, in rheumatoid arthritis. Sci Rep. 2016;6(1):29713. doi: 10.1038/srep29713.
   PubMedGoogle Scholar
• Fadda S, Hamdy A, Abulkhair E, et al. Serum levels of osteoprotegerin and RANKL in patients with rheumatoid arthritis and their relation to bone mineral density and disease activity. Egypt Rheumatol. 2015;37(1):1–6. doi: 10.1016/j.ejr.2014.06.001.
   Google Scholar
• Al-Rubaie HA, Al-Bayaa I, Al-Amiri Y. The value of soluble transferrin receptor and soluble transferrin receptor-ferritin ındex in discriminating ıron deficiency anaemia from anaemia of chronic disease in patients With rheumatoid arthritis. TORJ. 2019;13(1):9–14. doi: 10.2174/1874312901913010009.
   Google Scholar
• Jarlborg M, Gabay C. Systemic effects of IL-6 blockade in rheumatoid arthritis beyond the joints. Cytokine. 2022;149:155742. doi: 10.1016/j.cyto.2021.155742.
   PubMed Web of Science ®Google Scholar
• Xu S, Wang Y, Lu J, et al. Osteoprotegerin and RANKL in the pathogenesis of rheumatoid arthritis-induced osteoporosis. Rheumatol Int. 2012;32(11):3397–3403. doi: 10.1007/s00296-011-2175-5.
   PubMed Web of Science ®Google Scholar
• Sato H, Takai C, Kazama JJ, et al. Serum hepcidin level, iron metabolism and osteoporosis in patients with rheumatoid arthritis. Sci Rep. 2020;10(1):9882. doi: 10.1038/s41598-020-66945-3.
   PubMedGoogle Scholar
• Peyrin-Biroulet L, Williet N, Cacoub P. Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review. Am J Clin Nutr. 2015;102(6):1585–1594. doi: 10.3945/ajcn.114.103366.
   PubMed Web of Science ®Google Scholar
• Stefanova K, Delcheva G, Stankova T, et al. sRANKL, OPG and sRAGE as markers of bone metabolism in rheumatoid arthritis: relation to indicators of impaired iron homeostasis and inflammation. CR Acad Bulg Sci. 2021;74(8):1238–1246. doi: 10.7546/CRABS.2021.08.16.
   Google Scholar
• Stefanova K, Delcheva G, Maneva A, et al. Pathobiochemical mechanisms relating iron homeostasis with parameters of inflammatory activity and autoimmune disorders in rheumatoid arthritis. Folia Med (Plovdiv). 2018;60(1):124–132. doi: 10.1515/folmed-2017-0068.
   PubMedGoogle Scholar
• Wahle M. Anemia in patients with rheumatoid arthritis. Z Rheumatol. 2012;71(10):864–868. doi: 10.1007/s00393-011-0925-0.
   PubMed Web of Science ®Google Scholar
• Smith JT, Schneider AD, Katchko KM, et al. Environmental factors ımpacting Bone-Relevant chemokines. Front Endocrinol (Lausanne). 2017;8(8):22. doi: 10.3389/fendo.2017.00022.
   PubMedGoogle Scholar
• Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352(10):1011–1023. doi: 10.1056/NEJMra041809.
   PubMed Web of Science ®Google Scholar
• Weiss G. Iron metabolism in the anemia of chronic disease. Biochim Biophys Acta. 2009;1790(7):682–693. doi: 10.1016/j.bbagen.2008.08.006.
   PubMed Web of Science ®Google Scholar
• Pullerits R, D'Elia HF, Tarkowski A, et al. The decrease of soluble RAGE levels in rheumatoid arthritis patients following hormone replacement therapy is associated with increased bone mineral density and diminished bone/cartilage turnover: a randomized controlled trial. Rheumatology (Oxford). 2009;48(7):785–790. doi: 10.1093/rheumatology/kep079.
   PubMed Web of Science ®Google Scholar
• Kim KW, Kim BM, Moon HW, et al. Role of C-reactive protein in osteoclastogenesis in rheumatoid arthritis. Arthritis Res Ther. 2015;17(1):41. doi: 10.1186/s13075-015-0563-z.
   PubMedGoogle Scholar
• Roodman GD. Osteoclasts pump iron. Cell Metab. 2009;9(5):405–406. doi: 10.1016/j.cmet.2009.04.005.
   PubMed Web of Science ®Google Scholar
• Wang P, Li S, Liu LN, et al. Circulating osteoprotegerin levels are elevated in rheumatoid arthritis: a systematic review and meta-analysis. Clin Rheumatol. 2017;36(10):2193–2200. doi: 10.1007/s10067-017-3747-x.
   PubMed Web of Science ®Google Scholar
• Saidenberg-Kermanac’h N, Cohen-Solal M, Bessis N, et al. Role for osteoprotegerin in rheumatoid infammation. Joint Bone Spine. 2004;71(1):9–13. doi: 10.1016/S1297-319X(03)00131-3.
   PubMed Web of Science ®Google Scholar
• Van Steenbergen HW, Van Der Helm-van Mil AHM. Osteoprotegerin as biomarker for persistence of rheumatoid arthritis. Rheumatology (Oxford). 2016;55(5):949–950. doi: 10.1093/rheumatology/kev415.
   PubMed Web of Science ®Google Scholar
• Arida A, Nezos A, Papadaki I, et al. Osteoprotegerin and MTHFR gene variations in rheumatoid arthritis: association with disease susceptibility and markers of subclinical atherosclerosis. Sci Rep. 2022;12(1):9534. doi: 10.1038/s41598-022-13265-3.
   PubMed Web of Science ®Google Scholar